Valuation: Grand Pharmaceutical Group Limited

Market Cap 17.11B 2.18B 1.9B 1.8B 1.63B 3.05B 209B 3.07B 21.5B 8.3B 106B 8.19B 8.01B 342B P/E 2026 *
9.49x
P/E 2027 * 8.68x
Enterprise Value 17.11B 2.18B 1.9B 1.8B 1.63B 3.05B 209B 3.07B 21.5B 8.3B 106B 8.19B 8.01B 342B EV / Sales 2026 *
1.32x
EV / Sales 2027 * 1.21x
Free-Float
34.99%
Yield 2026 *
4.3%
Yield 2027 * 4.71%
1 day+1.84%
1 week+1.95%
Current month-0.90%
1 month-5.33%
3 months+3.86%
6 months-24.05%
Current year-36.62%
1 week 4.8
Extreme 4.795
5.06
1 month 4.7
Extreme 4.7
5.66
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
8.97
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 31/05/2021
Corporate Secretary 57 31/08/2011
Director TitleAgeSince
Director/Board Member 63 20/03/2005
Director/Board Member 66 11/05/2011
Director/Board Member 62 30/12/2018
Date Insider Type Main position Quantity % Market Cap. Importance
07/09/26 Other

Chief Executive Officer

21,500 0.0006%
22/04/26 Other

Chairman

50,000 0.0014%
21/04/26 Other

Chief Executive Officer

58,500 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%+1.95%-42.82%+22.84% 2.18B
+0.04%+3.34%+53.32%+102.40% 1,028B
-0.09%+1.66%+53.24%+65.73% 651B
-0.02%+2.66%+18.65%+71.84% 466B
+0.28%-1.08%+31.87%+42.40% 346B
+0.33%+1.39%+17.50%+24.58% 266B
-0.77%+2.21%+8.02%+14.11% 259B
+1.55%+2.20%+35.12%+42.07% 208B
-0.90%-0.32%-27.06%-56.48% 191B
-0.52%+4.45%+31.57%+97.98% 186B
Average +0.17%+3.25%+17.94%+42.75% 360.39B
Weighted average by Cap. -0.00%+3.09%+34.36%+61.78%

Financials

2026 *2027 *
Net sales 12.94B 1.65B 1.44B 1.36B 1.23B 2.31B 158B 2.32B 16.27B 6.28B 80.48B 6.2B 6.06B 259B 14.1B 1.8B 1.57B 1.48B 1.34B 2.52B 172B 2.53B 17.73B 6.84B 87.69B 6.75B 6.6B 282B
Net income 1.83B 233M 203M 192M 174M 326M 22.34B 327M 2.3B 886M 11.36B 875M 855M 36.54B 1.99B 254M 221M 209M 190M 355M 24.35B 357M 2.5B 966M 12.38B 953M 932M 39.83B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,326
Date Price Change Volume
21/09/26 HK$4.975 +1.84% 8,336,500
18/09/26 HK$4.885 -1.11% 7,017,500
17/09/26 HK$4.940 -0.90% 1,849,000
16/09/26 HK$4.985 +1.63% 4,862,498
15/09/26 HK$4.905 +0.51% 3,477,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.885HKD
Average target price
9.527HKD
Spread / Average Target
+95.02%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!